SNN Stock: Smith & Nephew plc Stock Price, Analysis & Insights
Get live SNN stock price $31.04, comprehensive Smith & Nephew plc stock analysis, charts, news, and expert forecast. Real-time SNN stock data and investment insights.
Loading chart data...
Smith & Nephew plc (SNN) Overview
Smith & Nephew plc (SNN) is a publicly traded company in the Healthcare sector , specifically within the Medical - Devices industry . As of the latest trading session, SNN trades at $31.04 with a market capitalization of 13.17B . Over the past 52 weeks, SNN has traded between $28.40 and $38.79 , with the current price positioned at approximately 25% of this range . The stock currently trades at...
Key Takeaways
- Operates in the Healthcare sector (Medical - Devices)
- Market cap: 13.17B
- Current price: $31.04
- 52-week range: $28.40 - $38.79
- P/E ratio: 21.70
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Smith & Nephew plc, along with its various subsidiary companies, operates globally in the research, development, manufacturing, marketing, and distribution of medical devices. The company's orthopedic reconstruction portfolio includes knee implants d...
Company Information
- CEO
- Deepak S. Nath
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 17349
Contact Information
- Website
- https://www.smith-nephew.com
- Address
- Building 5
- Country
- GB
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 21.7)
✓ Lower volatility stock (Beta: 0.67) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Smith & Nephew plc shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Smith & Nephew plc
- ⚠Investors should consider how Smith & Nephew plc fits within their overall portfolio allocation
Market Cap
13.17B
P/E Ratio (TTM)
21.70
Beta
0.67
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare SNN with peer companies:
- Price
- $65.52
- Market cap
- 32.35B
- Price
- $67.72
- Market cap
- 13.21B
- Price
- $22.33
- Market cap
- 11.99B
- Price
- $76.01
- Market cap
- 16.97B
- Price
- $468.48
- Market cap
- 13.38B
- Price
- $163.15
- Market cap
- 16.40B
- Price
- $54.69
- Market cap
- 23.52B
- Price
- $49.99
- Market cap
- 8.72B
- Price
- $162.57
- Market cap
- 14.00B
- Price
- $89.08
- Market cap
- 17.23B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.